NCT06989359Phase 2Recruiting

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

Study sponsor: ADARx Pharmaceuticals, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2028-12-31Estimated

Enrollment · participants45Estimated

Source updated2026-09-03Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-04-22 · 1 field changed

Primary completion date

Recorded edit

− Previous value

2027-07

+ Updated value

2028-12-31

Check registry source

Posted 2026-01-22 · 2 fields changed

Enrollment · participant count

Recorded edit

− Previous value

count: 30; type: ESTIMATED

+ Updated value

count: 45; type: ESTIMATED

Recruitment status

Recorded edit

− Previous value

Not yet recruiting

+ Updated value

Recruiting

Check registry source